Patents by Inventor Philippe Yves-Rémy Simon

Philippe Yves-Rémy Simon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteasome inhibiting ?-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders
    Patent number: 11053249
    Abstract: The present invention relates generally to proteasome inhibiting ?-lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 6, 2021
    Assignees: Philippe Yves-Remy Simon, VITA API
    Inventors: Philippe Yves-Rémy Simon, Henri Oreal, Gérard Audran, Marvin Schulz, Jean-Patrick Joly, Didier Siri, Anouk Siri
  • Proteasome Inhibiting Beta-Lactam Produrgs Useful for the Treatment of Cancer and Nurodegenerative Disorders
    Publication number: 20200216455
    Abstract: The present invention relates generally to proteasome inhibiting ?-lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.
    Type: Application
    Filed: December 22, 2017
    Publication date: July 9, 2020
    Applicants: Vita Api, Etat Français Représenté Par le Directeur Central du Service de Santé des Armées, Université D'Aix-Marseille, Centre National de la Recherche Scientifique
    Inventors: Philippe Yves-Rémy Simon, Henri Oreal, Gérard Audran, Marvin Schulz, Jean-Patrick Joly, Didier Siri, Anouk Siri